Innovative profile of the Russian pharmaceutical industry

Podshivalova, Mariya; Pylaeva, Irina; Almrshed, Sattar

doi:10.32609/0042-8736-2021-6-139-156

Cited by 3 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This, ultimately, gives such enterprises the opportunity to reveal their innovative potential at the stage of deep maturity. This conclusion correlates with the results of the empirical studies (Morck and Yeung, 2001;Podshivalova et al, 2021), the authors of which concluded that small firms realize their innovative potential only at the stage of maturity, when they have accumulated the appropriate capital. In addition, the obtained results helped us identify a new reason for the low innovation activity of small industrial enterprises-the insufficient number of mature manufacturing companies.…”

Section: The Long-lived Sample Groupsupporting

confidence: 86%

Examining the interaction of sustainable innovation activity and the life cycle of small high‐tech enterprises

2021

Self Cite

View full text Add to dashboard Cite

The direction of this study was engineered by the need to increase the innovation activity of high-tech enterprises (primarily small enterprise) and to test the hypothesis that the innovation activity of such enterprises depends on the stage of their life cycle. At the first stage, we formulated the assumptions and prerequisites for the formation of a sample for the study: 106 small enterprises of the electric power industry of the Chelyabinsk region of Russia Federation. At the second stage, we developed a method to determine an enterprise's life cycle stage, taking into account the specifics of small industrial enterprises. Our method involves the sequential implementation of two steps. In the first, we use the traditional indicator of age of the enterprise, and in the second, we assess the degree of stability of key financial indicators of enterprise activities. At the third stage, based on the proposed method, the sample was divided into three groups: growing, mature, and long-lived enterprises, for each of which an assessment of innovation activity was carried out. As a result, we determined that small Russian enterprises in the high-tech industry demonstrate an increase in innovation activity at the stage of maturity, as a rule. However, even at this stage, only one in three enterprises shows such activity. This can be explained by the low demand for small businesses in the Russian national innovation system, as well as the lack of highly qualified personnel and the prevailing stereotypes of attitudes toward small businesses. As captured in the Sustainable Development Goals (SDGs) 9 (industry, innovation, and infrastructure), the proposed approach can be applied in the development of regional support programs and strategies for the development of small high-tech enterprises.

show abstract

Section: The Long-lived Sample Groupsupporting

confidence: 86%

Examining the interaction of sustainable innovation activity and the life cycle of small high‐tech enterprises

2021

Self Cite

View full text Add to dashboard Cite

show abstract

A new approach to identifying high-tech manufacturing SMEs with sustainable technological development: Empirical evidence

Pylaeva

Podshivalova

Alola

et al. 2022

Journal of Cleaner Production

View full text Add to dashboard Cite

The impact of the COVID-19 pandemic on the sustainable development of pharmaceutical companies: Evidence from Russia

2022

View full text Add to dashboard Cite

Nowadays there are two perspectives on the COVID-19 pandemic: it has become a threat to sustainable economic development and the pharmaceutical industry has turned out to be its main beneficiary. The purpose of this article is to empirically verify the correctness of these statements. The data sample consists of 1771 enterprises of Russian pharmaceutical industry over a 14-year period. The methods used consisted of positioning maps and pairwise comparison of the financial indicators for 2020 with the two most severe crises in the Russian economy (2009 and 2015), as well as with the period of the most sustainable development (2007) and the legacy year (2019). In order to assess the uniformity of the pandemic impact on the industry, we identified analytical groups based on the scale of enterprises and life cycle stages. The main result is to reveal the uneven pandemic impact on the sustainable development of pharmaceutical industry producers. Small young companies were the main beneficiaries of the pandemic. The micro-enterprises in the pharmaceutical industry were the most severely affected. However, the analysis has shown that the pandemic was not the main cause of their instability. In addition, the study as a whole proves the presence of a certain stress resistance of domestic pharmaceutical producers to crises of various nature.

show abstract

Innovative profile of the Russian pharmaceutical industry

Cited by 3 publications

References 24 publications

Examining the interaction of sustainable innovation activity and the life cycle of small high‐tech enterprises

Examining the interaction of sustainable innovation activity and the life cycle of small high‐tech enterprises

A new approach to identifying high-tech manufacturing SMEs with sustainable technological development: Empirical evidence

The impact of the COVID-19 pandemic on the sustainable development of pharmaceutical companies: Evidence from Russia

Contact Info

Product

Resources

About